Swiss Lions 100 | 2026 edition
Bachem
Bachem is No. 89 in the Swiss Lions 100 and No. 13 in Life Sciences & Health, with a score of 36.1 out of 100. Headquarters: Bubendorf, canton of Basel-Landschaft.
- Swiss Lions score
- 36.1
- Overall rank
- 89of 100
- Life Sciences & Health
- 13of 14
About
Maker of peptides and oligonucleotides as active ingredients for medicines, headquartered in Bubendorf, Basel-Landschaft.
How the score is made
Global scale
CHF 709m revenue.
Swiss value
Swiss made: Partly.
Prominence
Online attention across languages, and worldwide search interest.
Impact
Near-term target validated. Not a certified B Corp.
Philanthropy
None found.
Key figures
- Revenue used in the ranking
- CHF 709mTTM Oct 2026, company
- Revenue
- CHF 709mTwelve months to 30 June 2026
- Net profit
- CHF 149mAttributable to shareholders
- Dividends paid
- CHF 67mTo all shareholders
- Employees worldwide
- 2,725
Employees in Switzerland and dividends paid to Swiss shareholders are not published consistently, so they are not shown.
Profile
- Headquarters
- BubendorfCanton of Basel-Landschaft
- Language region
- German-speaking
- Category
- Life Sciences & Health
- Ownership
- Listed
- Main customers
- Businesses (B2B)
- Chief executive
- Anne-Kathrin StollerSince 2026. Source
- Founded
- 1971
Nearby in the Swiss Lions 100
Also in Life Sciences & Health
1RocheScore 80.8
2NovartisScore 78.6
3LonzaScore 59.5
4SonovaScore 54.8
5SandozScore 54.5
6StraumannScore 53.5
See all 14 brands in Life Sciences & Health.
Sources
- Revenue used in the ranking: stockanalysis.com BANB (TTM Oct 2026).
- Revenue, net profit, dividends and employees: stockanalysis.com, from company filings.
- Climate target: Science Based Targets initiative dashboard, October 2026. Foundations: Swiss commercial register. B Corp: B Lab directory.
Something out of date?
If a figure is wrong, or Bachem can publish figures for the next edition, tell us. Corrections are recorded with their source.